Call for earlier Detection of Alzheimer's Disease and foster brighter connections with TauTrack
Over 55 MILLION people worldwide are living with dementia, and Alzheimer’s
disease accounts for 60-70%of these cases (WHO, 2023).
In China alone, from
1990 to 2021 the
incidence of
Alzheimer's Disaser
occuring increased by
242.5%
1990 to 2021 the
incidence of
Alzheimer's Disaser
occuring increased by
242.5%
Alzheimer'sdiseaseis the leading cause of dementia worldwide, driven by abnormal proteinbuild-up, including amyloid-β and
tau, in and around brain cells. BD-tau(brain-derived tau)is a newblood-based biomarker
that outperforms plasma total-tau and showss pecificity to Alzheimer's disease,
Current Method
Current
methods
for
detecting
Alzheimer’s
disaese
rely
oncerebrospinal
fluid
(CSF)
test
s
and
PET
brain
scans.
While
mostly
accurate,
these
approaches
are
not
easily
accessible,
invasive,
and
expensive,
which
limits
their
use
for
early
diagnosis
and
widespread
screening.
Our Method
With
the
specificity
of
BD
tau(brain-derived
tau)
to
Alzheimer’s
Disease,using
an
high
affinity
aptamer
can
effectly
reflect
brain
damage
caused
by
Alzheimer's
disease
and
reliably
distinguish
it
from
other
neurodegenerative
disorders,
offering
a
less
invasive
and
more
accessible
diagnostic
tool.
Our Method’s Advantages:
ACCURATE
LESS INVASIVE
AFFORDABLE
From
Lab
to
Loved
Ones:
Ending
Alzheimer’s
Silence
